Wednesday - April 16, 2025
Record net revenue and net cash provided by operating activities for the fourth quarter of 2022
CALGARY, AB, April 24, 2023 /CNW/ - SNDL Inc. (NASDAQ: SNDL) ("SNDL" or the "Company") reported its financial and operational results for the full year and fourth quarter ended December 31, 2022. All financial information in this press release is reported in millions of Canadian dollars unless otherwise indicated. Liquor retail includes operations for the period of March 31, 2022, to December 31, 2022, and cannabis retail includes the operations of Nova Cannabis Inc. ("Nova") retail stores for the period of March 31, 2022, to December 31, 2022.
The Company will hold a conference call and webcast at 10:30 a.m. EST (8:30 a.m. MST) on Tuesday, April 25, 2023. The conference call details can be found below.
SNDL's acquisition of The Valens Company ("Valens") closed in January of 2023. The combined entities create a low-cost vertically integrated Canadian company generating over a billion dollars in annualized pro forma revenue. Through the combination of a diverse portfolio of brands, a 197 store multi-banner cannabis retail network, low-cost biomass sourcing, premium indoor cultivation and low-cost manufacturing facilities, SNDL expects to be one of the largest adult-use cannabis manufacturers and retailers in Canada. The Valens transaction is expected to accelerate the optimization and rationalization of SNDL's manufacturing and operational footprint to better address market saturation and oversupply while also generating synergies in the Company's manufacturing operations.
"2022 was another transformational year for SNDL. We increased the sustainability of our business model by achieving record-breaking revenue and gross margin as well as positive and increasing cash provided from operating activities in our two most recent quarters," said Zach George, Chief Executive Officer of SNDL. "Our vertical integration strategy is beginning to show its intended results, and we are working to gain stability in a challenging and dynamic industry. Our acquisition of Valens provides midstream capabilities in every material cannabis product category and the ability to selectively balance higher cost cultivation costs while taking advantage of the current massive oversupply in Canadian markets. We now expect to materially outperform our originally contemplated savings and are on target to realize more than $20.0 million in cost synergies. Despite the positive milestones and growth we have achieved, SNDL's shares are trading at near all-time lows, well below our book value and materially less than 1X our annualized revenue. We must continue to find ways to unlock value and evaluate all options regarding the future of our business and operating segments. Sustainability is a key priority, which means sustainably profitable operations, sustainable product quality, and sustainable environmental practices. Our drive to create exceptional consumer products and experiences is key to SNDL's momentum and future success. We continue to see positive results across all of our key operating segments and remain committed to our goal of becoming free cash flow positive."
OPERATING SEGMENTS | ||||||
($000s) | Liquor | Cannabis | Cannabis | Investments | Corporate | Total |
As at December 31, 2022 | ||||||
Total assets | 351,338 | 200,393 | 163,130 | 825,151 | 19,338 | 1,559,350 |
Three months ended December 31, 2022 | ||||||
Net revenue | 159,745 | 68,402 | 12,258 | — | — | 240,405 |
Gross margin | 36,927 | 15,650 | (9,009) | — | — | 43,568 |
Interest and fee revenue | — | — | — | 5,989 | — | 5,989 |
Investment (loss) income | — | — | — | (6,868) | — | (6,868) |
Share of loss of equity-accounted investees | — | — | — | (18,291) | — | (18,291) |
Depreciation and amortization | 11,303 | 3,879 | 190 | — | 6,251 | 21,623 |
Income (loss) before income tax | (1,316) | (98,374) | (12,932) | (28,641) | (18,932) | (160,195) |
As at December 31, 2021 | ||||||
Total assets (1) | — | 157,022 | 147,887 | 1,093,596 | 29,155 | 1,427,660 |
Three months ended December 31, 2021 | ||||||
Net revenue | — | 9,951 | 12,768 | — | — | 22,719 |
Gross margin (1) | — | 2,840 | (7,350) | — | — | (4,510) |
Interest and fee revenue | — | — | — | 3,647 | — | 3,647 |
Investment loss | — | — | — | (41,755) | — | (41,755) |
Share of profit of equity-accounted investees | — | — | — | 19,271 | — | 19,271 |
Depreciation and amortization (1) | — | (427) | 666 | — | 428 | 667 |
Income (loss) before income tax (1) | — | 312 | (23,190) | (23,176) | (2,919) | (48,973) |
(1) Adjustments to provisional amounts have been made in the comparative period due to the finalization of business combination accounting for the Inner Spirit acquisition. Refer to note 5(b) in the Company's Audited Financial Statements and the notes thereto for the year ended December 31, 2022 |
SNDL's business is operated and reported in four segments: Liquor Retail, Cannabis Retail, Cannabis Operations and Investments.
SNDL is Canada's largest private sector liquor retailer, operating 169 locations, predominantly in Alberta, under its three retail banners: Wine and Beyond, Liquor Depot and Ace Liquor. The Company's Liquor Retail segment brought material stability and opportunity to SNDL in 2022. SNDL's Liquor segment strengthens SNDL's broader regulated retail technology infrastructure, the ability to own the customer relationship and the expertise to shape the customer retail experience.
With its ownership interest in Nova, SNDL is Canada's largest private sector cannabis retailer, operating 197 locations under its four retail banners: Value Buds, Spiritleaf, Superette and Firesale Cannabis. SNDL's Cannabis Retail strategy is based on a number of factors, including the quality of its store locations, the range of products it offers, and the unique experiences it provides to customers. The use of data and insights from a large volume of monthly transactions enables SNDL to leverage technology and analytics to inform and improve its retail strategy.
The Cannabis Operations segment is a key enabler of SNDL's vertical integration strategy. As many LPs shift towards an 'asset-light' model, SNDL is dedicated to taking on the challenging and capital-intensive tasks necessary to deliver top-quality products to consumers. The success of this segment depends on a combination of factors, including a diverse portfolio of brands, a multi-banner cannabis retail network, low-cost biomass sourcing, premium indoor cultivation, and efficient manufacturing facilities. With these advantages, SNDL has now become one of the largest manufacturers of adult-use cannabis products in Canada.
Three months ended | Year ended | |||
($000s) | 2022 | 2021 | 2022 | 2021 |
Interest and fee revenue | ||||
Interest revenue from investments at amortized cost | 923 | 861 | 3,660 | 1,654 |
Interest and fee revenue from investments at Fair Value | 2,282 | 2,116 | 6,036 | 8,514 |
Interest revenue from cash | 2,784 | 670 | 7,043 | 2,981 |
5,989 | 3,647 | 16,739 | 13,149 | |
Investment revenue | ||||
Realized gains | — | 1,995 | 389 | 20,213 |
Unrealized losses | (6,868) | (43,750) | (65,553) | (64,714) |
(6,868) | (41,755) | (65,164) | (44,501) | |
Revenue from direct investments | (879) | (38,108) | (48,425) | (31,352) |
Share of profit (loss) of equity-accounted investees | (18,291) | 19,271 | (43,002) | 32,913 |
Total investment activities | (19,170) | (18,837) | (91,427) | 1,561 |
SNDL remains focused on building long-term shareholder value through vertical integration, accretive deployment of cash resources, expansion of its retail distribution network, enhanced offerings of high-quality brands within both the Cannabis Operations and Cannabis Retail segments, and further streamlining of the Company's operating structure.
The strategic value of SNDL's vertical integration is unfolding as the Company is delivering exceptional products and services to its valued customers. The Company is leveraging its ability to capitalize on its diverse portfolio of brands, its efficient manufacturing facilities, and its commitment to low-cost biomass sourcing and premium indoor cultivation to maintain its position as a leading manufacturer, retailer and industry partner in the adult-use cannabis market.
The integration of SNDL and Valens is anticipated to deliver substantial benefits in the form of cost rationalization and operational efficiencies. A detailed bottom-up analysis of available synergies is currently in progress, and the Company is uncovering further cost savings. SNDL expects to realize more than $20 million in annual cost synergies as a result of this process, exceeding the $10 million that was announced in January 2023. Additionally, enhanced distribution of Valens products through the SNDL retail network is expected to generate incremental revenue, which is also being evaluated and realized. The Company looks forward to providing updates on the progress of these synergies with reporting on the first quarter of 2023 and believes that this transaction will enhance SNDL's competitive position and generate value for its shareholders.
Certain specified financial measures in this news release are non-IFRS measures. These terms are not defined by IFRS and, therefore, may not be comparable to similar measures provided by other companies. These non-IFRS financial measures should not be considered in isolation or as an alternative for or superior to measures of performance prepared in accordance with IFRS. These measures are presented and described in order to provide shareholders and potential investors with additional measures in understanding the Company's operating results in the same manner as the management team.
Adjusted EBITDA is a non-IFRS measure which the Company uses to evaluate its operating performance. Adjusted EBITDA provides information to investors, analysts, and others to aid in understanding and evaluating the Company's operating results in a manner similar to its management team. Adjusted EBITDA is defined as net income (loss) from continuing operations before finance costs, depreciation and amortization, accretion expense, income tax recovery and excluding changes in fair value of biological assets, changes in fair value realized through inventory, unrealized foreign exchange gains or losses, unrealized gains or losses on marketable securities, changes in fair value of derivative warrants, share-based compensation expense, asset impairment, gain or loss on disposal of property, plant and equipment and certain one-time non-operating expenses, as determined by management. The Company presents both consolidated or total Adjusted EBITDA and Adjusted EBITDA by operating segment.
OPERATING SEGMENTS | ||||||
($000s) | Liquor | Cannabis | Cannabis | Investments | Corporate | Total |
Three months ended December 31, 2022 | ||||||
Net earnings (loss) | (1,316) | (98,374) | (12,932) | (30,017) | (18,932) | (161,571) |
Adjustments | ||||||
Finance costs | (2,599) | (57) | 19 | 9,098 | — | 6,461 |
Change in estimate of fair value of | — | (27) | — | — | (3,900) | (3,927) |
Loss on cancellation of contracts | — | — | (290) | — | — | (290) |
Depreciation and amortization | 11,303 | 3,879 | 190 | — | 6,251 | 21,623 |
Income tax recovery | — | — | — | 1,376 | — | 1,376 |
Change in fair value of biological | — | — | 2,712 | — | — | 2,712 |
Change in fair value realized through | — | — | 279 | — | — | 279 |
Unrealized foreign exchange (gain) | 3 | (4) | 25 | — | — | 24 |
Unrealized (gain) loss on marketable | — | — | — | 6,868 | — | 6,868 |
Share-based compensation | — | 372 | — | — | 2,588 | 2,960 |
Asset impairment | 10,079 | 97,299 | 283 | — | — | 107,661 |
Loss (gain) on disposition of PP&E | 17 | 14 | 471 | — | — | 502 |
Cost of sales non-cash component (1) | — | — | 1,702 | — | — | 1,702 |
Inventory impairment (recovery) and | — | — | 3,467 | — | — | 3,467 |
Restructuring costs | — | — | — | 212 | — | 212 |
Transaction costs | — | — | — | — | 2,392 | 2,392 |
Government subsidies | — | — | — | — | — | — |
Other expenses | — | — | — | — | — | — |
Adjusted EBITDA | 17,487 | 3,102 | (4,074) | (12,463) | (11,601) | (7,549) |
OPERATING SEGMENTS | ||||||
($000s) | Liquor | Cannabis | Cannabis | Investments | Corporate | Total |
Three months ended December 31, 2021 | ||||||
Net earnings (loss) | — | (9,746) | (23,190) | (20,905) | (2,919) | (56,760) |
Adjustments | ||||||
Finance costs | — | — | — | 3,300 | 230 | 3,530 |
Change in estimate of fair value of | — | — | — | — | (8,200) | (8,200) |
Loss on cancellation of contracts | — | — | 5,116 | — | — | 5,116 |
Depreciation and amortization | — | (427) | 666 | — | 428 | 667 |
Income tax recovery | — | 10,058 | — | (2,271) | — | 7,787 |
Change in fair value of biological | — | — | (2,158) | — | — | (2,158) |
Change in fair value realized through | — | — | 1,756 | — | — | 1,756 |
Unrealized foreign exchange (gain) | — | — | — | — | (1) | (1) |
Unrealized (gain) loss on marketable | — | — | — | 43,750 | — | 43,750 |
Share-based compensation | — | — | — | — | 2,443 | 2,443 |
Asset impairment | — | — | — | — | — | — |
Loss (gain) on disposition of PP&E | — | (374) | — | — | — | (374) |
Cost of sales non-cash component (1) | — | — | 772 | — | — | 772 |
Inventory impairment and | — | — | 9,702 | — | — | 9,702 |
Restructuring costs | — | — | — | 874 | — | 874 |
Transaction costs | — | — | — | — | 7,837 | 7,837 |
Government subsidies | — | — | — | — | — | — |
Other expenses | — | — | — | — | — | — |
Adjusted EBITDA | — | (489) | (7,336) | 24,748 | (182) | 16,741 |
(1) Cost of sales non-cash component is comprised of depreciation expense | ||||||
This press release is intended to be read in conjunction with the Company's Financial Statements and Notes for the period ended December 31, 2022, and the accompanying Management's Discussion and Analysis ("MD&A"). These reports are available under the Company's profile on SEDAR at www.sedar.com and EDGAR at www.sec.gov/edgar.shtml.
The Company will hold a conference call and webcast at 10:30 a.m. EST (8:30 a.m. MST) on Tuesday, April 25, 2023.
To access the live webcast of the call, please visit the following link:
https://services.choruscall.ca/links/sndl2022q4.html
A telephone replay will be available for one month. To access the replay, dial:
Canada/USA Toll Free: 1-800-319-6413 or International Toll: +1-604-638-9010
When prompted, enter Replay Access Code: 0070 #
The webcast archive will be available for three months via the link provided above.
SNDL is a public company whose shares are traded on the Nasdaq under the symbol "SNDL." SNDL is the largest private-sector liquor and cannabis retailer in Canada with retail banners that include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, Spiritleaf, Superette and Firesale Cannabis. SNDL is a licensed cannabis producer and one of the largest vertically integrated cannabis companies in Canada specializing in low-cost biomass sourcing, premium indoor cultivation, product innovation, low-cost manufacturing facilities, and a cannabis brand portfolio that includes Top Leaf, Contraband, Citizen Stash, Sundial Cannabis, Palmetto, Bon Jak, Spiritleaf Selects, Versus Cannabis, Value Buds, Vacay, Grasslands and Superette. SNDL's investment portfolio seeks to deploy strategic capital through direct and indirect investments and partnerships throughout the global cannabis industry. For more information on SNDL, please go to www.sndl.com.
This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"), including, but not limited to, statements regarding the Company's operational goals, demand for the Company's products, the Company's ability to achieve profitability or its goal of sustainable, positive gross margin and positive free cash flow, the development of the legal cannabis industry, performance of the Company's investments, including through the SunStream joint venture, any potential forms of shareholder value creation, and the expansion of product offerings, brand and market share and retail networks, and the realization of expected benefits from the acquisition of Valens, Zenabis and Superette, and its expectation that it may become a majority owner of one or more MSOs in 2023, its expectation to be one of the largest adult-use cannabis manufacturers and retailers in Canada, its expectation to materially outperform its originally contemplated savings and its estimated cost synergies. Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "likely", "outlook", "forecast", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. Please see "Item 3.D.—Risk Factors" in the Company's annual report on Form 20-F, filed with the Securities and Exchange Commission ("SEC") on April 24, 2023, and the risk factors included in our other SEC filings for a discussion of the material risk factors that could cause actual results to differ materially from the forward-looking information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
Last Trade: | US$1.33 |
Daily Volume: | 946,005 |
Market Cap: | US$353.190M |
April 09, 2025 January 21, 2025 November 05, 2024 |
COPYRIGHT ©2025 GREEN STOCK NEWS